Research participants undergo careful evaluation by study physicians and are closely followed by the medical staff.
All our enrolling studies have been conducted on humans and are safe before potential research participants become involved. There is never a charge to the participant or insurance as the cost of medical research is paid for by the pharmaceutical company that sponsors the research program.
Age: 21-70
Condition: Overweight patients with a BMI of 30-45 who will be provided tirzepatide to lose 15% of your body weight. To follow, an upper GI endoscopy with a groundbreaking procedure called a DMR to see if it will help maintain your weight loss. (Can not be Diabetic)
Age: 40-75
Condition: Post Menopausal, bothersome Hot Flashes
Age: 21-70 with an A1c 7.5-10
Condition: Type 2 Diabetics using Insulin, total daily use of 20u-100u or can also only be on oral or injectable other diabetic medications. Age 21-70. BMI 24-40. This is a new approach to Type 2 Diabetes evaluating a non-drug procedure that may help improve blood sugar without increasing medicines or insulin and could help with weight loss.
Age: 4-30
Condition: Type 1 or Type 2 Diabetics that use a self monitoring glucose device to manage their Diabetes.
Age: 18- 50 year-old women who suffer with Endometriosis with moderate to severe pain and heavy periods.
Condition: Women with heavy menstrual cycles and or moderate to severe pain and has a diagnosis of endometriosis.
Age: 18 -75
Condition: Diagnosed with Gout and taking Allopurinol every day for the last 4 weeks (100-800mg) or have been on Allopurinol in the past but not taking now. Must have had at least 2 Gout flares in the last 12 months. BMI 18-45.1
Age: 18 or older
Condition: IBS/Diarrhea with pain or cramping most days
Age: 18-45
Condition: Endometriosis with Moderate to Severe pain in premenopausal women.
Investigators Research Group, LLC | 321 E. Northfield Drive, Suite 100 Brownsburg, Indiana 46112 | [email protected]